• Corpus ID: 30992079

Insertional mutagenesis and autoimmunity induced disease caused by human fetal and retroviral residual toxins in vaccines.

@article{Jarzyna2016InsertionalMA,
  title={Insertional mutagenesis and autoimmunity induced disease caused by human fetal and retroviral residual toxins in vaccines.},
  author={Peter A. Jarzyna and Ngoc V Doan and Theresa A. Deisher},
  journal={Issues in law \& medicine},
  year={2016},
  volume={31 2},
  pages={
          221-234
        }
}
IntroductionMajor concern of vaccination regarding childhood diseases in terms of Insertional Mutagenesis and AutoimmunityThe potential consequences of injecting our children with human fetal DNA contaminants include two well-established pathologies:1) Insertional mutagenesis in which fetal DNA incorporates into the child's DNA causing mutations.2) Autoimmune disease triggered by the human fetal DNA in vaccines leading a child's immune system to attack his or her own body.VaccinesUnited States… 

Misapplication of the Precautionary Principle has Misplaced the Burden of Proof of Vaccine Safety

Human health can be protected in government policies if the precautionary principle is used in the correct format that puts the onus of proof of harmlessness on the government and pharmaceutical industry, and not the general public.

mRNA, Nanolipid Particles and PEG: A Triad Never Used in Clinical Vaccines is Going to Be Tested on Hundreds of Millions of People

  • Alejandro Sousa
  • Medicine
    Biomedical Journal of Scientific & Technical Research
  • 2021
This work presents a new approach to characterize and conservation of biological diversity in the context of infectious disease by utilizing a probabilistic approach, based on data from three studies conducted in Spain.

References

SHOWING 1-7 OF 7 REFERENCES

Risks linked to endogenous retroviruses for vaccine production: a general overview.

Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo

Direct in vivo gene modification, such as that demonstrated here, would allow for gene therapy in systemic diseases or in cells that cannot be manipulated ex vivo.

Creation of human tumour cells with defined genetic elements

It is shown that the ectopic expression of the telomerase catalytic subunit (hTERT) in combination with two oncogenes results in direct tumorigenic conversion of normal human epithelial and fibroblast cells.

Increased Mutagenesis and Unique Mutation Signature Associated with Mitotic Gene Conversion

Observations suggest that increased DSB frequencies in oncogene-activated mammalian cells may also increase the probability of acquiring mutations required for transition to a cancerous state.

Rare copy number variants in neuropsychiatric disorders: Specific phenotype or not?

The results confirm the etiological candidacy of the six selected CNV regions for neuropsychiatric diseases and suggest that the neurodevelopmental component is larger in the etiology of schizophrenia and intellectual disability than in mood disorders and deletions are in general more pathogenic than duplications.

Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.

Data suggest that triplex formation can occur between an exogenous oligodeoxyribonucleotide and duplex DNA in the nucleus of treated cells.